Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Amarin Corporation plc

< Previous 1 2 3 4 Next >
News headline image
Amarin Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
From Amarin Corporation plc
Via GlobeNewswire
Tickers AMRN
News headline image
Amarin Announces Preliminary Voting Results Following 2023 General Meeting of Shareholders
From Amarin Corporation plc
Via GlobeNewswire
Tickers AMRN
News headline image
Amarin and CSL Seqirus Announce Exclusive License and Distribution Agreement to Commercialize VAZKEPA® (Icosapent Ethyl) in Australia and New Zealand
From Amarin Corporation plc
Via GlobeNewswire
Tickers AMRN ASX CSLLY
News headline image
Amarin Sets the Record Straight on Sarissa’s Latest Misstatements
From Amarin Corporation plc
Via GlobeNewswire
Tickers AMRN
News headline image
Amarin Corporation to Present New Data Evaluating VASCEPA®/VAZKEPA® (Icosapent Ethyl) at ACC.23/WCC
From Amarin Corporation plc
Via GlobeNewswire
Tickers AMRN
News headline image
Amarin to Present at Cowen's 43rd Annual Health Care Conference
From Amarin Corporation plc
Via GlobeNewswire
Tickers AMRN
News headline image
Amarin to Report Fourth Quarter and Full Year 2022 Financial Results And Host Conference Call on March 1st, 2023
From Amarin Corporation plc
Via GlobeNewswire
Tickers AMRN
News headline image
Amarin Urges Shareholders to Vote “Against” Sarissa’s Harmful Proposals at Upcoming General Meeting – IT HAS NO PLAN, NO NEW IDEAS AND AN UNDERQUALIFIED SLATE
From Amarin Corporation plc
Via GlobeNewswire
Tickers AMRN
News headline image
Leading Independent Proxy Firm ISS Joins Glass Lewis in Recommending that Amarin Shareholders Vote “AGAINST” Sarissa’s Value-Destructive Proposals
From Amarin Corporation plc
Via GlobeNewswire
Tickers AMRN
News headline image
Amarin Clearly and Definitively Instructed Registrar to Accept ALL Submitted Proxy Cards
From Amarin Corporation plc
Via GlobeNewswire
Tickers AMRN
News headline image
Leading Independent Proxy Advisory Firm Glass Lewis Recommends that Amarin Shareholders Vote “AGAINST” All of Sarissa’s Proposals
From Amarin Corporation plc
Via GlobeNewswire
Tickers AMRN
News headline image
Amarin Shareholders Invited to Webcast with Board and Management Team
From Amarin Corporation plc
Via GlobeNewswire
Tickers AMRN
News headline image
Amarin Mails Letter Highlighting Why Shareholders Should Vote on the WHITE Proxy Card “AGAINST” Sarissa’s Harmful Proposals
From Amarin Corporation plc
Via GlobeNewswire
Tickers AMRN
News headline image
Amarin Mails Letter to Shareholders Highlighting Sarissa’s Myths vs. The Facts
From Amarin Corporation plc
Via GlobeNewswire
Tickers AMRN
News headline image
Amarin Mails Letter to Shareholders Highlighting New Board and Superior Leadership
From Amarin Corporation plc
Via GlobeNewswire
Tickers AMRN
News headline image
Amarin Files Definitive Proxy Materials and Mails Letter to Shareholders
From Amarin Corporation plc
Via GlobeNewswire
Tickers AMRN
News headline image
Amarin Announces VAZKEPA® (Icosapent Ethyl) Approved By Medsafe In New Zealand
From Amarin Corporation plc
Via GlobeNewswire
Tickers AMRN
News headline image
Amarin to Present at SVB Securities Global Biopharma Conference
From Amarin Corporation plc
Via GlobeNewswire
Tickers AMRN
News headline image
Amarin Responds to Inaccurate and Misleading Statement by Sarissa
From Amarin Corporation plc
Via GlobeNewswire
Tickers AMRN
News headline image
Amarin Comments on Sarissa’s Notice to Call a Special Meeting of Amarin Shareholders
From Amarin Corporation plc
Via GlobeNewswire
Tickers AMRN
News headline image
Amarin Provides Preliminary Fourth Quarter and Full Year 2022 Revenue and Cash Position and Priorities for 2023
From Amarin Corporation plc
Via GlobeNewswire
Tickers AMRN
News headline image
Amarin Board of Directors Announces Appointment of Murray W. Stewart, DM FRCP
From Amarin Corporation plc
Via GlobeNewswire
Tickers AMRN
News headline image
Amarin to Present at the 41st Annual J.P. Morgan Healthcare Conference
From Amarin Corporation plc
Via GlobeNewswire
Tickers AMRN
News headline image
Amarin Announces VAZKEPA® (icosapent ethyl) Receives Regulatory Approval in Switzerland
From Amarin Corporation plc
Via GlobeNewswire
Tickers AMRN
News headline image
Amarin Announces VAZKEPA® (icosapent ethyl) Approved by the Therapeutic Goods Administration (TGA) in Australia
From Amarin Corporation plc
Via GlobeNewswire
Tickers AMRN
News headline image
Amarin to Present at Jefferies London Healthcare Conference
From Amarin Corporation plc
Via GlobeNewswire
Tickers AMRN
News headline image
Amarin Highlights Key Data Presented at American Heart Association 2022 Scientific Sessions for VASCEPA®/VAZKEPA (icosapent ethyl) and Patient Care
From Amarin Corporation plc
Via GlobeNewswire
Tickers AMRN
News headline image
Amarin Reports Third Quarter 2022 Financial Results and Provides Business Update
From Amarin Corporation plc
Via GlobeNewswire
Tickers AMRN
News headline image
Amarin Appoints Adam Berger and Geraldine Murphy to Board of Directors
From Amarin Corporation plc
Via GlobeNewswire
Tickers AMRN
News headline image
Amarin to Report Third Quarter 2022 Financial Results And Host Conference Call on October 27, 2022
From Amarin Corporation plc
Via GlobeNewswire
Tickers AMRN
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.